FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Noven Pharmaceuticals Daytrana Recall

Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1

Noven Pharmaceuticals Inc · Miami, FL

Risk level
Class II
Reported by FDA
Dec 7, 2022
Recall ID
D-0071-2023
Check your lot numberHow we source this data

Summary

Noven Pharmaceuticals recalled Daytrana starting Nov 16, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0071-2023 on Dec 7, 2022. Reason: Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches. Status: Ongoing.

Why it was recalled

Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

Product description

Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5553-3.

Lot numbers, UPCs & expiration codes

Lot: 91316 Exp. 02/2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0071-2023
Classification
Class II
Status
Ongoing
Recall initiated
Nov 16, 2022
FDA report date
Dec 7, 2022
Quantity
3977 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Noven Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0071-2023, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Ongoing
Country
United States
Event ID
91161
Address
11960 Sw 144th St
Code information
Lot: 91316 Exp. 02/2023
Postal code
33186-6109
Report date
Dec 7, 2022
Product type
Drugs
Recall number
D-0071-2023
Classification
Class II
Recalling firm
Noven Pharmaceuticals Inc
Product quantity
3977 boxes
Reason for recall
Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5553-3.
Distribution pattern
Nationwide in the USA
Recall initiation date
Nov 16, 2022
Initial firm notification
Letter
Center classification date
Nov 28, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0071-2023, published Dec 7, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls